NORDIC PHARMACEUTICALS ApS: Financial statements 2013
CVR: 27430015
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 808,383 and a net result of DKK 189,528 compared with DKK 421,244 the year before. That is a decrease of 15.7% compared with the year before. Equity in the 2013 report amounted to DKK 610,625. The solvency ratio was 37%.
- Gross Profit
- DKK 808,383
- Profit/Loss
- DKK 189,528
- Equity
- DKK 610,625
- Total Assets
- DKK 1,651,312
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 808 t. | 190 t. | 611 t. | - |
| 2012 | - | 959 t. | 421 t. | 614 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
NORDIC PHARMACEUTICALS ApS has published its annual report for 2012. Gross profit came to DKK 959,032, and the net result was DKK 421,244.
About NORDIC PHARMACEUTICALS ApS
NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.